Viking Global Investors LP Deciphera Pharmaceuticals, Inc. Transaction History

Viking Global Investors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$19.08 - $36.14 $14 Million - $26.6 Million	-735,898 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$33.57 - $42.1 $22.3 Million - $27.9 Million	-662,893 Reduced 47.39%	735,898 $28.5 Million
Q2 2018 Aug 14, 2018	SELL	$20.06 - $44.95 $13.2 Million - $29.7 Million	-660,051 Reduced 32.06%	1,398,791 $55 Million
Q1 2018 May 15, 2018	SELL	$20.04 - $29.71 $6.73 Million - $9.98 Million	-335,783 Reduced 14.02%	2,058,842 $41.3 Million
Q4 2017 Feb 14, 2018	SELL	$16.54 - $24.2 $1.6 Million - $2.35 Million	-96,917 Reduced 3.89%	2,394,625 $54.3 Million
Q3 2017 Nov 14, 2017	BUY	$17.65 - $18.99 $44 Million - $47.3 Million	2,491,542	2,491,542 $47.3 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

Stay updated on Viking Global Investors LP with notifications on news.